Document is current
Any future updates will be listed below
-
Authors
Krumm, Brian E.
Roth, Bryan L.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01MH112205, R01MH112205)
- License Information
-
More Information
Article History
Received: 1 January 2025
Accepted: 20 March 2025
First Online: 12 May 2025
Competing interests
: B.L.R. is currently on the SAB of Epiodyne and Septerna Pharmaceuticals. UNC has licensed technologies from BLR’s lab to many pharmaceutical and Biotechnology companies. All other authors declare no competing interest.
